Miromatrix Medical Inc. Common Stock
MIRO
MIRO was delisted on the 12th of December, 2023.
32 hedge funds and large institutions have $8.78M invested in Miromatrix Medical Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 2 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
0% more funds holding
Funds holding: 32 → 32 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
24% less capital invested
Capital invested by funds: $11.6M → $8.78M (-$2.84M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$77.2K |
| 2 |
LWAM
Legacy Wealth Asset Management
Woodbury,
Minnesota
|
+$58.4K |
| 3 |
GS
Gagnon Securities
New York
|
+$24.7K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.6K |
| 5 |
HI
Harbour Investments
Madison,
Wisconsin
|
+$3.96K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$27K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$20.4K |
| 3 |
GIPM
G2 Investment Partners Management
New York
|
-$17.6K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$3.56K |
| 5 |
BlackRock
New York
|
-$3.26K |
MIRO Hedge Fund Activity: Q3 2023 in Review
32 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Miromatrix Medical Inc. Common Stock (MIRO) for Q3 2023, worth a combined $8.78M — down 24% from $11.6M a quarter earlier.
Fund positioning in MIRO was balanced in Q3 2023: 2 funds opened new positions, 2 closed out, 9 added to existing stakes and 6 trimmed.
The largest buyer was First Light Asset Management, adding an estimated $77.2K. The largest seller was Royal Bank of Canada, exiting entirely with an estimated $27K sold.
- 32 institutional investors held Miromatrix Medical Inc. Common Stock (MIRO) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $8.78M of Miromatrix Medical Inc. Common Stock stock for Q3 2023, down 24% quarter-over-quarter.
- 2 funds opened new Miromatrix Medical Inc. Common Stock positions in Q3 2023 and 2 closed out, a net change of 0 holders.
- The largest Miromatrix Medical Inc. Common Stock buyer in Q3 2023 was First Light Asset Management, an estimated $77.2K added.
- The largest Miromatrix Medical Inc. Common Stock seller in Q3 2023 was Royal Bank of Canada, an estimated $27K sold.
Based on aggregated 13F filings for Q3 2023.